Company Tekla Healthcare Opportunities Fund Nyse

Closed End Funds

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Closed End Funds

Inactive Instrument

End-of-day quote Nyse Other stock markets
-	-

2023	Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund and Tekla Healthcare Investors Approves Election of Rose Dimartino, C. William Maher, Todd Reit and Stephen Bird as New Trustees	CI
2023	Tekla Healthcare Opportunities Fund authorizes a Buyback Plan.	CI

abrdn Healthcare Opportunities Fund (the Fund), formerly Tekla Healthcare Opportunities Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. The Fund invests up to 20 % of managed assets, measured at the time of investment, in the debt of healthcare companies. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. It invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.

USD in Million	2022	Weight	2023	Weight	Delta
Investment and Related Activities 100.0 %	70	100.0 %	81	100.0 %	+15.72%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	70	100.0 %	81	100.0 %	+15.72%

Managers	Title	Age	Since
Dan Omstead CEO	Chief Executive Officer	71	13-12-31
Laura Woodward CMP	Compliance Officer	56	13-12-31
Jason Akus PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Rakesh Kumar Jain BRD	Director/Board Member	74	13-12-31
Dan Omstead CEO	Chief Executive Officer	71	13-12-31
C. Maher BRD	Director/Board Member	63	23-10-26
Stephen Bird BRD	Director/Board Member	57	23-10-26
Jeffrey Bailey BRD	Director/Board Member	62	19-12-31
Rose F. DiMartino BRD	Director/Board Member	-	23-10-26
Thomas Kent BRD	Director/Board Member	71	16-12-31
Todd Reit BRD	Director/Board Member	56	23-10-26
Kathleen Goetz BRD	Director/Board Member	-	21-12-08
Mark Watson BRD	Director/Board Member	74	22-06-08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	41,356,058	41,354,057 ( 100.00 %)	0	100.00 %

Name	Equities	%	Valuation
Morgan Stanley Smith Barney LLC 3.501 %	1,447,475	3.501 %	29 M
Cornerstone Advisors LLC (North Carolina) 2.152 %	889,767	2.152 %	18 M
Raymond James Financial Services, Inc. 2.080 %	859,863	2.080 %	17 M
RBC Capital Markets LLC 2.002 %	827,752	2.002 %	17 M
Raymond James & Associates, Inc. 1.929 %	797,275	1.929 %	16 M
Heron Bay Capital Management LLC 1.229 %	508,047	1.229 %	10 M
Saba Capital Management LP 1.194 %	493,572	1.194 %	10 M
1607 Capital Partners LLC 1.148 %	474,494	1.148 %	10 M
AQR Arbitrage LLC 0.9153 %	378,396	0.9153 %	8 M
Ameriprise Financial Services LLC 0.8644 %	357,326	0.8644 %	7 M

abrdn Healthcare Opportunities Fund

100 Federal Street 19th floor

02110, Boston

+215 405 5700

http://www.teklacap.com/funds/thq/

address Tekla Healthcare Opportunities Fund

Financials

Collective Investments

Collective Investments

Closed End Funds

Closed End Funds

	1st Jan change	Capi.
ARES CAPITAL CORPORATION	+3.74%	12.61B
PERSHING SQUARE HOLDINGS, LTD.	+5.50%	9.01B
FS KKR CAPITAL CORP.	-3.20%	5.41B
SPROTT PHYSICAL URANIUM TRUST FUND	+2.44%	5.25B
PIMCO DYNAMIC INCOME FUND	+5.63%	5.19B
SPROTT PHYSICAL SILVER TRUST	+14.36%	4.48B
SPROTT PHYSICAL GOLD AND SILVER TRUST	+16.67%	4.44B
MACQUARIE KOREA INFRASTRUCTURE FUND	+1.53%	4B
3I INFRASTRUCTURE PLC	+1.56%	3.75B